Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Election restrictions on announcements-vaccine info

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Aug 30, 2021 4:17pm

164 Views

Post# 33782960

RE:Election restrictions on announcements-vaccine info

Doesn't matter in my opinion Sysenti that has nothing to do with the Phase2 study for NMIBC. Currently Theralase's quest for a highly effective vaccine that would work on all Coronavirus strains & variants are in preclinical mode and I could be wrong here but I'm sure the next step would be with a animal study so again I'm my opinion that isn't world shaking news.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks